Compelling experimental evidence exists for a potent invasion suppress
or role of the cell-cell adhesion molecule E-cadherin. In addition, a
tumour suppressor effect has been suggested for E-cadherin. In human c
ancers, partial or complete loss of E-cadherin expression correlates w
ith malignancy. To investigate the molecular basis for this altered ex
pression we developed a comprehensive PCR/SSCP mutation screen for the
human E-cadherin gene, For 49 breast cancer patients the occurrence o
f tumour-specific mutations in the E-cadherin gene was examined. No re
levant DNA changes were encountered in any of 42 infiltrative ductal o
r medullary breast carcinoma samples, In contrast, four out of seven i
nfiltrative lobular breast carcinomas harboured protein truncation mut
ations (three nonsense and one frameshift) in the extracellular part o
f the E-cadherin protein. Each of the four lobular carcinomas with E-c
adherin mutations showed tumour-specific loss of heterozygosity of chr
omosomal region 16q22.1 containing the E-cadherin locus. In compliance
with this, no E-cadherin expression was detectable by immunohistochem
istry in these four tumours. These findings offer a molecular explanat
ion for the typical scattered tumour cell growth in infiltrative lobul
ar breast cancer.